These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. The absence of indoleamine 2,3-dioxygenase expression protects against NMDA receptor-mediated excitotoxicity in mouse brain. Mazarei G; Budac DP; Lu G; Lee H; Möller T; Leavitt BR Exp Neurol; 2013 Nov; 249():144-8. PubMed ID: 23994717 [TBL] [Abstract][Full Text] [Related]
14. Kynurenine 3-hydroxylase inhibition in rats: effects on extracellular kynurenic acid concentration and N-methyl-D-aspartate-induced depolarisation in the striatum. Urenjak J; Obrenovitch TP J Neurochem; 2000 Dec; 75(6):2427-33. PubMed ID: 11080194 [TBL] [Abstract][Full Text] [Related]
15. The novel KMO inhibitor CHDI-340246 leads to a restoration of electrophysiological alterations in mouse models of Huntington's disease. Beaumont V; Mrzljak L; Dijkman U; Freije R; Heins M; Rassoulpour A; Tombaugh G; Gelman S; Bradaia A; Steidl E; Gleyzes M; Heikkinen T; Lehtimäki K; Puoliväli J; Kontkanen O; Javier RM; Neagoe I; Deisemann H; Winkler D; Ebneth A; Khetarpal V; Toledo-Sherman L; Dominguez C; Park LC; Munoz-Sanjuan I Exp Neurol; 2016 Aug; 282():99-118. PubMed ID: 27163548 [TBL] [Abstract][Full Text] [Related]
16. Metabolic control of kynurenic acid formation in the rat brain. Hodgkins PS; Schwarcz R Dev Neurosci; 1998; 20(4-5):408-16. PubMed ID: 9778579 [TBL] [Abstract][Full Text] [Related]
17. A review of chromatographic methods for bioactive tryptophan metabolites, kynurenine, kynurenic acid, quinolinic acid, and others, in biological fluids. Fukushima T; Umino M; Sakamoto T; Onozato M Biomed Chromatogr; 2022 May; 36(5):e5308. PubMed ID: 34978092 [TBL] [Abstract][Full Text] [Related]
18. The kynurenine pathway in neurodegenerative diseases: mechanistic and therapeutic considerations. Tan L; Yu JT; Tan L J Neurol Sci; 2012 Dec; 323(1-2):1-8. PubMed ID: 22939820 [TBL] [Abstract][Full Text] [Related]
19. A new pathway of D-tryptophan metabolism: enzymic formation of kynurenic acid via D-kynurenine. TASHIRO M; TSUKADA K; KOBAYASHI S; HAYAISHI O Biochem Biophys Res Commun; 1961 Nov; 6():155-60. PubMed ID: 13919748 [No Abstract] [Full Text] [Related]
20. The kynurenine pathway modulates neurodegeneration in a Drosophila model of Huntington's disease. Campesan S; Green EW; Breda C; Sathyasaikumar KV; Muchowski PJ; Schwarcz R; Kyriacou CP; Giorgini F Curr Biol; 2011 Jun; 21(11):961-6. PubMed ID: 21636279 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]